Latest immune response News | Page 13

Top 3 Covid vaccine questions – Difference between vaccination and immunisation, myocarditis and pericarditis
Third dose of Covid vaccines for people who are severely immunocompromised
RTS,S malaria vaccine explained
Cloaking technology: helping therapeutic cells evade your immune system
Booster shot for severely immunocompromised Australians
Research may help explain immune response to Covid in children
New evidence on how breastmilk prevents food allergies
AZD7442 request for Emergency Use Authorization for Covid prophylaxis filed in US
Can we use wound healing immune response to treat sarcoma after surgery?
Researchers Illuminate Working Mechanism of Important Drug Target Proteins
WHO prioritizes access to diabetes and cancer treatments in new Essential Medicines Lists
Melbourne-made Covid treatment could future-proof Australia
AstraZeneca Covid and RSV presentations at IDWeek 2021 will showcase scientific progress in infectious diseases
Scientists progress groundbreaking electroceutical research
Innate immune response may predict Covid severity
Institute for Glycomics awarded $2.66 million in NHMRC funding
NHMRC Ideas Grant to support development UniSA-Sementis peanut allergy vaccine
NHMRC Ideas Grants success
Heart and kidney disease research wins national funding
E-liquid flavour names cloud toxicity levels
Testing on patients begins for new experimental drug for sepsis
Australia secures 20 million extra Astra Zeneca vaccines for onshore manufacturing
Australia secures 20 million extra Astra Zeneca vaccines
Update on University of Queensland COVID-19 vaccine
Update on UQ COVID-19 vaccine
Discovery provides hope for early detection of serious COVID-19
Shedding light on sex differences in COVID-19 mortality
Differences in immunity and blood vessels likely protect children from severe COVID-19
Malaria and immunology researchers win Burnet Prize
When there is good vaccine news – efficacy is only beginning of story
Expert commentary: Oxford and AstraZeneca vaccine preliminary Phase III data
Nanobodies could hold clues to new COVID-19 therapies
Study to determine cyclosporine’s role in treating hospitalized COVID-19 patients
Sustained COVID-19 immunity promising for vaccine effectiveness
Study reveals immune cells’ COVID memory
Sydney to undertake clinical studies of needle-free vaccine patch
Monash researchers reveal COVID immunity lasts up to eight months, giving hope for long-term protection by vaccines
$41.7 million boost to commercialise lifesaving medical discoveries
WEHI director named 2020 Melburnian of Year
Department of Defense funds development of a new Lyme disease vaccine
Altered ‘coat’ disguises fatal brain virus from neutralizing antibodies
Trial of Oxford coronavirus vaccine in Southampton shows strong immune response in older adults
Arthritis drug effective in treating sickest COVID-19 patients
Houston companies awarded top honors at premier life science venture capital conference
Biological E. Limited and Baylor COVID-19 vaccine begins clinical trial in India
Baylor COVID-19 vaccine begins clinical trial in India
Southampton Professor to lead Janssen COVID-19 vaccine trial
Drug research pivoted from prostate cancer to COVID-19 treatment